We investigate issues in the regulation and oversight of research aimed at the development of future therapies using iPSCs. In addition to overseeing the operations of the Facility for iPS Cell Therapy (FiT), which will maintains and provide clinical-grade iPSCs, we also work to develop culture methods for the generation of cells of assured quality. We further provide technical and facilities support to other CiRA labs. The division both strives to establish reliable methods for iPS cell generation and maintenance within the institute, and to provide guidance for other researchers working with these cells around the world. Prof. Shinya Yamanaka leads this division.